Karen Krasney

Currently holds a position at Capricor Therapeutics Inc

Position	Company	Period
Executive Vice President, General Counsel	Capricor Therapeutics Inc	Nov. 22, 2013 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2026-05-04	2026-05-01	Capricor Therapeutics Inc (CAPR)	PlS Planned sale	52,955 -4.1% 42.10 US$1,141,450	52,955 -4.1%	42.10	US$1,141,450
2026-05-04	2026-05-01	Capricor Therapeutics Inc (CAPR)	PlS Planned sale	30,430 -32.2% 120.43 US$3,908,331	30,430 -32.2%	120.43	US$3,908,331
2026-04-01	2026-03-31	Capricor Therapeutics Inc (CAPR)	PlS Planned sale	84,304 -37.7% 301.07 US$2,542,335	84,304 -37.7%	301.07	US$2,542,335
2026-03-31	2026-03-31	Capricor Therapeutics Inc (CAPR)	PrS Proposed sale	75,000 27.77 US$2,082,750	75,000	27.77	US$2,082,750